CpG Island Methylator Phenotype in Human Colorectal Cancer
CpG Island Methylator Phenotype in Human Colorectal Cancer
批准号:
7489495
负责人:
PETER W LAIRD
金额:
$49.13万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2012-07-31
关键词:
AddressAgeAlcohol consumptionAnatomyBRAF geneBehaviorBenignCandidate Disease GeneCharacteristicsClassificationClinicalColonColorectal CancerColorectal NeoplasmsCooperative Family RegistryCountryCpG Island Methylator PhenotypeCpG IslandsDNADNA MethylationDefectDetectionDiagnosticEnvironmental Risk FactorEnzymesEpigenetic ProcessEtiologyFamily history ofFolateFrequenciesFundingGenderGene MutationGene SilencingGenesGeneticGenetic PolymorphismGenomeGenus ColaGerm-Line MutationGoalsHeterogeneityHormonesHumanHypermethylationInfiltrationIntakeInterdisciplinary StudyInvasiveKnowledgeLife StyleLocationLymphocyteMalignant - descriptorMapsMeatMetabolicMethodologyMethylationMismatch RepairMolecularMutationNumbersPathway interactionsPhenotypePolypsPopulationPrevalencePublishingRaceRecording of previous eventsReportingResearch InfrastructureResearch PersonnelResidual stateResourcesRisk FactorsSamplingSmoking HistorySomatic MutationSpecimenStandardizationStretchingStudy SubjectTechnologyTissuesVenousbasecell growthgenetic epidemiologygenome wide association studyimprovedlymph nodespromotersextooltumor
中文摘要
描述(由申请人提供):人类结直肠癌是遗传和表观遗传改变的结果,包括启动子CpG岛超甲基化。已经描述了结肠直肠肿瘤的子集具有异常高数量的高甲基化CpG岛,导致定义了独特的表型,称为"CpG岛甲基化表型"或"CIMP"。本提案的长期目标是研究CIMP状态与分子、人口统计学和组织病理学特征以及环境风险因素之间的关联,使用通过结直肠癌研究合作家庭登记处(Colon CFR)收集的结直肠癌样本,该组织是一个由NCI支持的联盟,旨在促进结直肠癌遗传流行病学的协作和跨学科研究。我们最近发表了一种改进的DMA甲基化标记物集和分析技术,可以在存档的结直肠癌标本中以高准确度有效地定义CIMP。我们建议1)使用通过Colon CFR收集的4,943例基于人群的结直肠癌样本,估计CIMP状态与年龄,性别,家族史,种族和原籍国之间的关联,2)估计CIMP状态与肿瘤位置,分级,浸润边缘,淋巴细胞浸润,直接扩散,淋巴结扩散,静脉扩散和残留相邻息肉类型(如果存在)之间的关联,和3)评估CIMP状态与选定的风险因素之间的关联,所述风险因素包括遗传和环境/生活方式因素,包括BRAF中的体细胞突变、MMR基因中的种系突变、吸烟史、红肉和酒精摄入、膳食叶酸摄入、叶酸代谢酶多态性和激素使用史。这项研究将有助于我们了解CIMP的病因,以及它与结直肠癌的其他分子和组织病理学特征的关系。结直肠癌涉及控制细胞生长和分裂的基因的变化。这些变化可以是结构性的,如基因突变,或者它们可以反映基因被使用的活跃程度的改变,称为表观遗传变化。这项研究将调查一些结直肠肿瘤如何获得异常高数量的表观遗传变化,长期目标是利用这些知识来阻断或逆转这些类型的有害变化。
英文摘要
DESCRIPTION (provided by applicant): Human colorectal cancer arises as a consequence of both genetic and epigenetic alterations, including promoter CpG island hypermethylation. A subset of colorectal tumors has been described to have an unusually high number of hypermethylated CpG islands, leading to the definition of a distinct phenotype, referred to as "CpG Island Methylator Phenotype", or "CIMP". The long-term objective of this proposal is to study the association between CIMP status and molecular, demographic, and histopathologic features, and environmental risk factors, using colorectal cancer samples collected through the Cooperative Family Registry for Colorectal Cancer Studies (Colon CFR), an NCI-supported consortium intended as a resource to promote collaborative and interdisciplinary studies in the genetic epidemiology of colorectal cancer. We have recently published an improved DMA methylation marker set and analysis technology with which CIMP can be efficiently defined with high accuracy in archival colorectal cancer specimens. We propose to 1) estimate the association between CIMP status and age, sex, family history, race and country of origin, using 4,943 population-based colorectal cancer samples collected through the Colon CFR, 2) estimate the association between CIMP status and tumor location, grade, invasive margin, lymphocytic infiltration, direct spread, lymph node spread, venous spread and type of residual adjacent polyp, if present, and 3) estimate the association between CIMP status and selected risk factors, both genetic and environmental/lifestyle factors, including somatic mutations in BRAF, germline mutations in the MMR genes, smoking history, red meat and alcohol intakes, dietary folate intake, folate metabolic enzyme polymorphisms and history of hormone use. This study will contribute to our understanding of the etiology of CIMP, and its relationship to other molecular and histopathologic features of colorectal cancer. Colorectal cancer involves changes to genes that control cell growth and division. These changes can be structural, as in the case of genetic mutations, or they can reflect an alteration in how actively the gene is being used, referred to as an epigenetic change. This study will investigate how some colorectal tumors acquire an unusually high number of epigenetic changes, with the long-term goal of using this knowledge to block or reverse these types of deleterious changes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome
-
批准号:10780718
-
项目类别:
-
资助金额:$78.62万
-
财政年份:2023
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10301849
-
项目类别:
-
资助金额:$45.6万
-
财政年份:2021
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10474482
-
项目类别:
-
资助金额:$44.69万
-
财政年份:2021
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10684894
-
项目类别:
-
资助金额:$44.69万
-
财政年份:2021
-
负责人:PETER W LAIRD
-
依托单位:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
-
批准号:10450874
-
项目类别:
-
资助金额:$59.7万
-
财政年份:2020
-
负责人:PETER W LAIRD
-
依托单位:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
-
批准号:10672187
-
项目类别:
-
资助金额:$59.7万
-
财政年份:2020
-
负责人:PETER W LAIRD
-
依托单位:
Progressive DNA Hypomethylation as a Measure of Mitotic History and Potential Contributor to Replicative Senescence.
-
批准号:10266860
-
项目类别:
-
资助金额:$59.7万
-
财政年份:2020
-
负责人:PETER W LAIRD
-
依托单位:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
-
批准号:10307617
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2018
-
负责人:PETER W LAIRD
-
依托单位:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
-
批准号:10533777
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2018
-
负责人:PETER W LAIRD
-
依托单位:
Cellular Epigenetic Heterogeneity as a Predeterminant of Malignant Transformation Potential
-
批准号:10064579
-
项目类别:
-
资助金额:$71.52万
-
财政年份:2018
-
负责人:PETER W LAIRD
-
依托单位:
Integrative Cancer Epigenomic Data Analysis Center (ICE-DAC)
-
批准号:10005291
-
项目类别:
-
资助金额:$50.45万
-
财政年份:2016
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8450761
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8625273
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8297718
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8635426
-
项目类别:
-
资助金额:$7.77万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8527891
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
The Role of DNA Methylation in Tumor Maintenance
-
批准号:8795305
-
项目类别:
-
资助金额:$2.51万
-
财政年份:2012
-
负责人:PETER W LAIRD
-
依托单位:
Visualizing the effect of epigenetic modifications on transcription and mutation
-
批准号:8470607
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2010
-
负责人:PETER W LAIRD
-
依托单位:
Visualizing the effect of epigenetic modifications on transcription and mutation
-
批准号:8137285
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2010
-
负责人:PETER W LAIRD
-
依托单位:
Visualizing the effect of epigenetic modifications on transcription and mutation
-
批准号:8267689
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2010
-
负责人:PETER W LAIRD
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: